Arbutus Biopharma Corp
ABUS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001447028
No open-market purchases or sales by Arbutus Biopharma Corp insiders were filed in the last 90 days; 176 institutions reported holding it in 13F filings for Q2 2026, worth $674.9M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Arbutus Biopharma Corp as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 131
- +13 vs. Q1 2024
- Shares held
- 96.7M
- +13.3M (+16.0%) vs. Q1 2024
- Total value
- $298.4M
- +$83.2M (+38.7%) vs. Q1 2024
- New holders
- 23
- 49 more added
- Sold out
- 10
- 30 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 176 | $674.9M |
| Q1 2026 | 167 | $625.4M |
| Q4 2025 | 172 | $586.9M |
| Q3 2025 | 166 | $536.4M |
| Q2 2025 | 163 | $365.0M |
| Q1 2025 | 168 | $390.1M |
| Q4 2024 | 154 | $340.3M |
| Q3 2024 | 144 | $389.2M |
| Q2 2024 | 131 | $298.4M |
| Q1 2024 | 119 | $215.2M |
| Q4 2023 | 112 | $197.4M |
| Q3 2023 | 99 | $143.8M |
| Q2 2023 | 111 | $152.4M |
| Q1 2023 | 122 | $189.3M |
| Q4 2022 | 114 | $126.3M |
| Q3 2022 | 127 | $89.1M |
| Q2 2022 | 113 | $120.0M |
| Q1 2022 | 119 | $130.6M |
| Q4 2021 | 123 | $154.4M |
| Q3 2021 | 100 | $149.8M |
| Q2 2021 | 91 | $87.6M |
| Q1 2021 | 94 | $86.5M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Arbutus Biopharma Corp; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ledgewood Wealth Advisors, LLC | 278,436 | $860.4K | 0.74% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 313,307 | $968.1K | 0.00% | +19,151+6.5% | Added |
| BNP Paribas Arbitrage, SA | 348,235 | $1.08M | 0.00% | −1,200−0.3% | Reduced |
| Bank of Montreal | 354,813 | $1.10M | 0.00% | +20,548+6.1% | Added |
| Charles Schwab Investment Management Inc | 380,583 | $1.18M | 0.00% | +41,368+12.2% | Added |
| Kennedy Capital Management, Inc. | 457,578 | $1.41M | 0.03% | +21,072+4.8% | Added |
| Wellington Management Group LLP | 475,011 | $1.47M | 0.00% | +23,706+5.3% | Added |
| Bank of New York Mellon Corp | 493,729 | $1.53M | 0.00% | +86,104+21.1% | Added |
| Freestone Capital Holdings, LLC | 546,252 | $1.69M | 0.06% | +546,252 | New |
| Susquehanna International Group, LLP | 566,968 | $1.75M | 0.00% | +532,033+1,522.9% | Added |
| Boothbay Fund Management, LLC | 612,277 | $1.89M | 0.06% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 651,427 | $2.01M | 0.04% | +277,967+74.4% | Added |
| Corbin Capital Partners, L.P. | 853,304 | $2.20M | 4.95% | 00.0% | Unchanged |
| Woodline Partners LP | 926,534 | $2.86M | 0.03% | −3,144,125−77.2% | Reduced |
| Northern Trust Corp | 1,051,325 | $3.25M | 0.00% | −5,279−0.5% | Reduced |
| Citigroup Inc | 1,141,313 | $3.53M | 0.00% | +914,425+403.0% | Added |
| Advisor Group Holdings, Inc. | 1,369,839 | $4.23M | 0.01% | +2,300+0.2% | Added |
| Rubric Capital Management LP | 1,681,090 | $5.19M | 0.14% | +1,681,090 | New |
| Hudson Bay Capital Management LP | 1,685,000 | $5.21M | 0.04% | −1,835,382−52.1% | Reduced |
| BlackBarn Capital Partners LP | 2,070,900 | $6.40M | 3.30% | 00.0% | Unchanged |
| State Street Corp | 2,934,481 | $9.07M | 0.00% | +322,591+12.4% | Added |
| FourWorld Capital Management LLC | 2,972,527 | $9.19M | 12.13% | −28,000−0.9% | Reduced |
| Adage Capital Partners GP, L.L.C. | 3,000,000 | $9.27M | 0.02% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 3,289,260 | $10.2M | 2.05% | +1,215,077+58.6% | Added |
| Geode Capital Management, LLC | 3,313,158 | $10.2M | 0.00% | +354,271+12.0% | Added |
| Vanguard Group Inc | 7,022,095 | $21.7M | 0.00% | +1,034,188+17.3% | Added |
| Two Seas Capital LP | 8,571,751 | $26.5M | 4.32% | +729,824+9.3% | Added |
| BlackRock Inc. | 11,552,066 | $35.7M | 0.00% | +1,147,447+11.0% | Added |
| Whitefort Capital Management, LP | 12,867,967 | $39.8M | 24.51% | +5,8150.0% | Added |
| Morgan Stanley | 20,960,268 | $64.8M | 0.01% | +12,129,971+137.4% | Added |
| Picton Mahoney Asset Management | 79 | – | – | +79 | New |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −99,055−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −62,439−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −50,110−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −19,644−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −13,268−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −11,033−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −10,482−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −4,340−100.0% | Sold out |
| Financial Synergies Wealth Advisors, Inc. | 0 | $0 | 0.00% | −3,600−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Cambridge Trust Co | – | – | – | – | Not filed |